Page last updated: 2024-12-09
alpha-acetyllysine methyl ester
Description
alpha-acetyllysine methyl ester: RN refers to the (L-Lys)-isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
N(alpha)-acetyl-L-lysine methyl ester : An alpha-amino acid ester obtained by formal condensation of the carboxy group of N(alpha)-acetyl-L-lysine with the hydroxy group of methanol. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]
Cross-References
| ID Source | ID |
|---|
| PubMed CID | 2724394 |
| CHEBI ID | 64859 |
| SCHEMBL ID | 2387748 |
| MeSH ID | M0190106 |
Synonyms (21)
| Synonym |
|---|
| n.alpha.-acetyl-l-lysine methyl ester |
| alme |
| methyl (2s)-2-acetamido-6-aminohexanoate |
| 6072-02-2 |
| alpha-acetyllysine methyl ester |
| alpha-acetyl-l-lysine methyl ester |
| l-lysine, n2-acetyl-, methyl ester |
| n(alpha)-acetyl-l-lysine methyl ester |
| methyl n-acetyl-l-lysinate |
| methyl n-acetyl-6-amino-l-norleucinate |
| CHEBI:64859 |
| methyl n(2)-acetyl-l-lysinate |
| methyl n(2)-acetyllysinate |
| SCHEMBL2387748 |
| HHOLXTXLQMKUGJ-QMMMGPOBSA-N |
| methyl 2-(acetylamino)-6-aminohexanoate # |
| AKOS030212055 |
| Q27133503 |
| acetyl-l-lysine methyl ester |
| EN300-24815087 |
| methyl (2s)-6-amino-2-acetamidohexanoate |
Drug Classes (5)
| Class | Description |
|---|
| L-lysine derivative | A proteinogenic amino acid derivative resulting from reaction of L-lysine at the amino group or the carboxy group, or from the replacement of any hydrogen of L-lysine by a heteroatom. |
| alpha-amino acid ester | The amino acid ester derivative obtained the formal condensation of an alpha-amino acid with an alcohol. |
| acetamides | Compounds with the general formula RNHC(=O)CH3. |
| methyl ester | Any carboxylic ester resulting from the formal condensation of a carboxy group with methanol. |
| primary amino compound | A compound formally derived from ammonia by replacing one hydrogen atom by an organyl group. |
| [compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Research
Studies (3)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 12.46
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| Metric | This Compound (vs All) |
|---|
| Research Demand Index | 12.46 (24.57) | | Research Supply Index | 1.79 (2.92) | | Research Growth Index | 4.25 (4.65) | | Search Engine Demand Index | 0.00 (26.88) | | Search Engine Supply Index | 0.00 (0.95) |
| |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 5 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |